1 min read
Add as a preferred source on Google

CVS Projects at Least $8.65 Adjusted EPS for 2027, Plans First-Half 2028 Split

The outlook follows a raised 2026 adjusted EPS floor of $8.20 and third-quarter adjusted EPS of $2.09.

An empty pharmacy aisle branches into two parallel paths / TokenPost.ai
An empty pharmacy aisle branches into two parallel paths / TokenPost.ai

CVS Health projected adjusted earnings of at least $8.65 per share in 2027 as it plans to separate its businesses into two publicly traded companies in the first half of 2028.

The company raised its 2026 adjusted earnings-per-share floor to at least $8.20 and reported adjusted earnings of $2.09 per share for the third quarter.

The planned separation would put about 9,000 pharmacies, mail pharmacy services, MinuteClinic and Health100 in CVS Pharmacy. A separate health care solutions company would include Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health.

Current CVS Health shareholders are expected to own shares in both companies. Completion depends on further steps, including a final board vote, an effective Form 10 filing and confirmation of the planned tax treatment.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…